Form 4: OnKure Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Isaac Manke, a Director of OnKure Therapeutics, Inc., reported multiple transactions in common stock on August 7, 2026.
Summary
- Grant/award: acquired 300,000 Stock Option (right to buy) on August 7, 2026; holds 300,000 after (Direct).
- Disposition to the issuer: disposed of 15,300 Stock Option (right to buy) on August 7, 2026 (Direct).
- Grant/award: acquired 15,300 Stock Option (right to buy) on August 7, 2026; holds 15,300 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Isaac Manke — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Stock Option (right to buy) | 300,000 | — | — | 300,000 |
| 2026-08-07 | Disposition to the issuer | Stock Option (right to buy) | 15,300 | — | — | 0 |
| 2026-08-07 | Grant/award | Stock Option (right to buy) | 15,300 | — | — | 15,300 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (300,000 shares) |
| 2026-08-07 | Disposition to the issuer (15,300 shares) |
| 2026-08-07 | Grant/award (15,300 shares) |
Keywords
insider transaction, Form 4, OKUR, OnKure Therapeutics, Inc., neutral, Isaac Manke
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.